candesartan has been researched along with Colitis in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizushima, T | 1 |
| Sasaki, M | 1 |
| Ando, T | 1 |
| Wada, T | 1 |
| Tanaka, M | 1 |
| Okamoto, Y | 1 |
| Ebi, M | 1 |
| Hirata, Y | 1 |
| Murakami, K | 1 |
| Mizoshita, T | 1 |
| Shimura, T | 1 |
| Kubota, E | 1 |
| Ogasawara, N | 1 |
| Tanida, S | 1 |
| Kataoka, H | 1 |
| Kamiya, T | 1 |
| Alexander, JS | 1 |
| Joh, T | 1 |
| Okawada, M | 1 |
| Koga, H | 1 |
| Larsen, SD | 1 |
| Showalter, HD | 1 |
| Turbiak, AJ | 1 |
| Jin, X | 1 |
| Lucas, PC | 1 |
| Lipka, E | 1 |
| Hillfinger, J | 1 |
| Kim, JS | 1 |
| Teitelbaum, DH | 1 |
2 other studies available for candesartan and Colitis
| Article | Year |
|---|---|
Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Adhesion | 2010 |
Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitis.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Com | 2011 |